• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSMD1或CSMD2的缺失可能导致结直肠癌患者预后不良。

Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

作者信息

Zhang Rui, Song Chun

机构信息

Department of Intestine Surgery, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, 110042, People's Republic of China.

出版信息

Tumour Biol. 2014 May;35(5):4419-23. doi: 10.1007/s13277-013-1581-6. Epub 2014 Jan 10.

DOI:10.1007/s13277-013-1581-6
PMID:24408017
Abstract

CUB and sushi multiple domain protein 1 (CSMD1) is a candidate tumor suppressor gene. The three members of CSMD family have very similar structures, each consisting of 14 CUB domains separated from one another by a sushi domain, an additional uninterrupted array of sushi domains, a single transmembrane domain, and a short cytoplasmic tail. In this work, we aimed to study the protein and mRNA levels of the CSMD1, CSMD2, and CSMD3 and evaluate their prognostic importance in colorectal cancer. Reduced expressions of these three proteins were detected in colorectal cancer tissues by comparing matched normal tissues. Low CSMD2 expression was significantly associated with differentiation, lymphatic invasion, and tumor size. CSMD3 was associated with differentiation and lymphatic invasion. CSMD1 and CSMD2 expressions were associated with overall survival. This study offers convincing evidence for the first time that the three genes of CSMD family were downregulated in the patients with colorectal cancer and may be used as predictors of colorectal cancer.

摘要

CUB和寿司多结构域蛋白1(CSMD1)是一种候选肿瘤抑制基因。CSMD家族的三个成员具有非常相似的结构,每个成员都由14个CUB结构域组成,这些结构域被一个寿司结构域、一个额外的连续寿司结构域阵列、一个单一的跨膜结构域和一个短的细胞质尾巴彼此隔开。在这项研究中,我们旨在研究CSMD1、CSMD2和CSMD3的蛋白质和mRNA水平,并评估它们在结直肠癌中的预后重要性。通过比较匹配的正常组织,在结直肠癌组织中检测到这三种蛋白质的表达降低。低CSMD2表达与分化、淋巴浸润和肿瘤大小显著相关。CSMD3与分化和淋巴浸润相关。CSMD1和CSMD2表达与总生存期相关。本研究首次提供了令人信服的证据,证明CSMD家族的这三个基因在结直肠癌患者中表达下调,并且可能用作结直肠癌的预测指标。

相似文献

1
Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.CSMD1或CSMD2的缺失可能导致结直肠癌患者预后不良。
Tumour Biol. 2014 May;35(5):4419-23. doi: 10.1007/s13277-013-1581-6. Epub 2014 Jan 10.
2
Identification of two new members of the CSMD gene family.CSMD基因家族两个新成员的鉴定。
Genomics. 2003 Sep;82(3):412-5. doi: 10.1016/s0888-7543(03)00149-6.
3
Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.Cub 和 Sushi 多结构域 1(CSMD1)基因的体细胞突变、等位基因缺失和 DNA 甲基化与结直肠癌患者的早期诊断相关。
PLoS One. 2013;8(3):e58731. doi: 10.1371/journal.pone.0058731. Epub 2013 Mar 7.
4
A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1.一个编码含有CUB和寿司多结构域蛋白质的新型巨大基因CSMD3:人类染色体8q23.3-q24.1上良性成人家族性肌阵挛性癫痫的候选基因。
Biochem Biophys Res Commun. 2003 Sep 12;309(1):143-54. doi: 10.1016/s0006-291x(03)01555-9.
5
Somatic mutations to CSMD1 in colorectal adenocarcinomas.结直肠癌中CSMD1的体细胞突变。
Cancer Biol Ther. 2008 Apr;7(4):609-13. doi: 10.4161/cbt.7.4.5623.
6
The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.CUB 和 Sushi 多结构域 1(CSMD1)在人类疾病中的多种作用。
Genes (Basel). 2022 Dec 10;13(12):2332. doi: 10.3390/genes13122332.
7
Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma.CSMD1 表达缺失与浸润性导管乳腺癌的高肿瘤分级和不良预后相关。
Breast Cancer Res Treat. 2010 Jun;121(3):555-63. doi: 10.1007/s10549-009-0500-4. Epub 2009 Aug 8.
8
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.补体抑制剂CSMD1在人类乳腺癌中发挥肿瘤抑制作用。
Oncotarget. 2016 Nov 22;7(47):76920-76933. doi: 10.18632/oncotarget.12729.
9
miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).微小RNA-10b通过靶向CUB和寿司多结构域蛋白1(CSMD1)的表达在人肝癌细胞中发挥致癌活性。
BMC Cancer. 2016 Oct 18;16(1):806. doi: 10.1186/s12885-016-2801-4.
10
Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.SCUBE2表达降低与结直肠癌的进展及预后相关。
Oncol Rep. 2015 Apr;33(4):1956-64. doi: 10.3892/or.2015.3790. Epub 2015 Feb 9.

引用本文的文献

1
Predicting immunotherapy prognosis and targeted therapy sensitivity of colon cancer based on a CAF-related molecular signature.基于CAF相关分子特征预测结肠癌的免疫治疗预后和靶向治疗敏感性
Sci Rep. 2025 Feb 21;15(1):6387. doi: 10.1038/s41598-025-90899-z.
2
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations.组织学特征不明确的子宫内膜癌常伴有TP53基因突变。
Virchows Arch. 2025 Apr;486(4):697-705. doi: 10.1007/s00428-024-03912-7. Epub 2024 Sep 5.
3
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.

本文引用的文献

1
Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.Cub 和 Sushi 多结构域 1(CSMD1)基因的体细胞突变、等位基因缺失和 DNA 甲基化与结直肠癌患者的早期诊断相关。
PLoS One. 2013;8(3):e58731. doi: 10.1371/journal.pone.0058731. Epub 2013 Mar 7.
2
CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.CSMD1 通过激活 Smad 通路在 A375 黑素瘤细胞中发挥抗肿瘤活性。
Apoptosis. 2012 Sep;17(9):927-37. doi: 10.1007/s10495-012-0727-0.
3
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.
补体抑制剂 CSMD1 的肿瘤抑制作用及其在 TNF 诱导的胶质瘤神经炎症中的作用。
J Exp Clin Cancer Res. 2024 Apr 1;43(1):98. doi: 10.1186/s13046-024-03019-6.
4
Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease.川崎病静脉注射免疫球蛋白反应的药物基因组学研究。
Front Immunol. 2024 Jan 8;14:1287094. doi: 10.3389/fimmu.2023.1287094. eCollection 2023.
5
Preliminary study on the role of the CSMD2 gene in bladder cancer.CSMD2基因在膀胱癌中作用的初步研究
Heliyon. 2023 Dec 1;10(1):e22593. doi: 10.1016/j.heliyon.2023.e22593. eCollection 2024 Jan 15.
6
Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population.癌症核心治疗靶点的多层次特征识别及面向更广泛患者群体的药物筛选
Front Pharmacol. 2023 Nov 23;14:1280099. doi: 10.3389/fphar.2023.1280099. eCollection 2023.
7
Multi-omics Analysis Classifies Colorectal Cancer into Distinct Methylated Immunogenic and Angiogenic Subtypes Based on Anatomical Laterality.多组学分析基于解剖学位置将结直肠癌分类为不同的甲基化免疫原性和血管生成亚型。
Indian J Surg Oncol. 2023 Jun;14(Suppl 1):209-219. doi: 10.1007/s13193-023-01760-6. Epub 2023 May 17.
8
The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.CUB 和 Sushi 多结构域 1(CSMD1)在人类疾病中的多种作用。
Genes (Basel). 2022 Dec 10;13(12):2332. doi: 10.3390/genes13122332.
9
Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker.CSMD2作为一种潜在的预后、诊断和免疫生物标志物的综合泛癌分析。
Front Genet. 2022 Aug 17;13:918486. doi: 10.3389/fgene.2022.918486. eCollection 2022.
10
MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis.微小 RNA-642b-3p 通过下调 CUB 和 sushi 多结构域蛋白 1/smad 轴在胃癌中发挥癌基因作用。
Bioengineered. 2022 Apr;13(4):9613-9627. doi: 10.1080/21655979.2022.2056813.
使用全外显子组测序鉴定非小细胞肺癌中的体细胞突变。
Carcinogenesis. 2012 Jul;33(7):1270-6. doi: 10.1093/carcin/bgs148. Epub 2012 Apr 17.
4
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
5
Voxelwise genome-wide association study (vGWAS).体素全基因组关联研究(vGWAS)。
Neuroimage. 2010 Nov 15;53(3):1160-74. doi: 10.1016/j.neuroimage.2010.02.032. Epub 2010 Feb 17.
6
Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma.CSMD1 表达缺失与浸润性导管乳腺癌的高肿瘤分级和不良预后相关。
Breast Cancer Res Treat. 2010 Jun;121(3):555-63. doi: 10.1007/s10549-009-0500-4. Epub 2009 Aug 8.
7
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.在大量原发性肺癌、头颈癌、乳腺癌和皮肤癌组织中对CSMD1进行特征分析。
Cancer Biol Ther. 2009 May;8(10):907-16. doi: 10.4161/cbt.8.10.8132. Epub 2009 May 9.
8
Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.8p23.2上的等位基因失衡和纯合缺失与肝癌发生的逐步进展有关。
Hepatology. 2009 Feb;49(2):513-22. doi: 10.1002/hep.22698.
9
Two patients with balanced translocations and autistic disorder: CSMD3 as a candidate gene for autism found in their common 8q23 breakpoint area.两名患有平衡易位和自闭症谱系障碍的患者:在其共同的8q23断裂点区域发现CSMD3作为自闭症的候选基因。
Eur J Hum Genet. 2008 Jun;16(6):696-704. doi: 10.1038/ejhg.2008.7. Epub 2008 Feb 13.
10
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.CSMD1是一种新型的多结构域补体调节蛋白,在中枢神经系统和上皮组织中高表达。
J Immunol. 2006 Apr 1;176(7):4419-30. doi: 10.4049/jimmunol.176.7.4419.